MedPath

Hemodynamic Assessment of the Right Ventricle Using Pressure-volume Loop Catheter and Pulmonary Artery Catheter in Patients Undergoing Left Ventricular Assist Device Placement

Recruiting
Conditions
Right Ventricular Dysfunction
Interventions
Diagnostic Test: Hemodynamic assessment
Registration Number
NCT04478890
Lead Sponsor
University of Minnesota
Brief Summary

This study will include the placement of a pressure volume (PV) loop catheter in the right atrium of patients undergoing left ventricular assist device (LVAD) placement and measure relevant PV loop data. Transesophageal echocardiography (TEE) and pulmonary artery (PA) catheter parameters as comparators to the PV loop will be recorded.

Detailed Description

This will be a prospective observational study design to characterize right ventricular function in 5 consecutive patients undergoing LVAD implantation at the University of Minnesota Medical Center (UMMC). Pre-, intra- and postoperative care delivery to all enrolled and consented patients will meet the standards of care otherwise delivered to patients undergoing LVAD implantation at UMMC; care delivery will be at the discretion of the clinical care team and will not be altered based on the output of the right ventricular high-fidelity conductance catheters.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
5
Inclusion Criteria
  • Patients undergoing left ventricular assist device (LVAD) placement at the University of Minnesota Medical Center
Read More
Exclusion Criteria
  • Patients with a history of internal jugular vein thrombosis or known reasons for not being able to thread a central venous catheter through either internal jugular vein
  • Patients with a history of known esophageal strictures, esophageal or stomach cancer, esophageal varices, or any patient in whom a TEE is contraindicated
  • Patients with permanent pacemakers whose right ventricle is being paced and not in normal sinus rhythm
  • Patients unable to consent to participating in the study
  • Patients who are pregnant will be excluded, as part of standard care, all female patients are screened for pregnancy prior to surgery.
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Observational GroupHemodynamic assessmentCharacterize right ventricular function while undergoing LVAD implantation
Primary Outcome Measures
NameTimeMethod
End-diastolic pressureApproximately 4-6 hours

End-diastolic pressure will be reported in units of mmHG

End-diastolic volumeApproximately 4-6 hours

End-diastolic volume will be reported in units of milliliters

Stroke workApproximately 4-6 hours

Stroke work will be reported in units of gram meters (g\*m)

End-systolic pressureApproximately 4-6 hours

End-systolic pressure will be reported in units of mmHG

Stroke volumeApproximately 4-6 hours

Stroke volume will be reported in units of millilitres per square metre

End-systolic volumeApproximately 4-6 hours

End-systolic volume will be reported in units of milliliters

Heart rateApproximately 4-6 hours

Heart rate will be reported in units of beats per minute

Ejection fractionApproximately 4-6 hours

Ejection fraction will be reported as a percent

Cardiac outputApproximately 4-6 hours

Cardiac output will be reported in units of milliliters per minute

Right ventricular dP/dtApproximately 4-6 hours

Right ventricular dP/dt will be reported in units of mmHg per second

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Minnesota

🇺🇸

Minneapolis, Minnesota, United States

© Copyright 2025. All Rights Reserved by MedPath